KALA BIO

KALA · NASDAQ

$0.1897+$0.0126 (+7.11%)TodayMarket closed ·
Prev close $0.1771

Latest news

  • NewsTanya Rawat

    KALA Bio (KALA) Shares Soar 57% After Hours: Here's Why

  • Press releaseNewsfile

    KALA Bio Signs Non-Binding LOI to Acquire Nationwide Telehealth Platform with Approximately $48 Million in Sales Since Inception

  • Press releaseGlobe Newswire

    Kala Bio and Virotek Sign Letter of Intent with U.S. DNA Testing Platform to Resell Virotek's Suite of Genetic Testing Products

  • News

    12 Health Care Stocks Moving In Tuesday's Intraday Session

  • NewsAvi Kapoor

    Dow Dips Over 300 Points; Medtronic Shares Gain After Upbeat Q1 Earnings

  • Press releaseGlobe Newswire

    Kala Bio and Virotek Announce Letter of Intent to Establish an Exclusive U.S. Distribution Partnership for Ophthalmology Genetic Testing Program

  • Press releaseGlobe Newswire

    Aterian, Inc. Announces Definitive Agreement for the Sale of its Marquee Brand Portfolio for $18 Million Subject to Adjustments

  • Press releaseGlobe Newswire

    Kala Bio Celebrates Trump Executive Order as Game-Changer for Psychedelic Medicine

  • News

    Kala Bio Q4 EPS $0.86 Beats $(1.44) Estimate, Sales $0.00

  • News

    12 Health Care Stocks Moving In Wednesday's Pre-Market Session

  • Press releaseGlobe Newswire

    Kala Bio Engages Dr. Saeid Babaei as Senior Scientific Advisor to Evaluate Clinical Assets and Precision Development Opportunities

  • Press releaseGlobe Newswire

    KALA BIO Delivers Industry-Leading AI Infrastructure: Bionic Intelligence Research Agent Now Live

  • NewsVandana Singh

    EXCLUSIVE: Penny Stock Kala Bio Transitions To Revenue Model With AI Platform Launch

  • Press releaseGlobe Newswire

    Red Light Holland Engages Kala Bio's Researgency.AI Platform to Support Clinical Development of Filament's Patented PEX010 Botanical Psilocybin Drug Candidate

  • News

    12 Health Care Stocks Moving In Thursday's Intraday Session

  • NewsAvi Kapoor

    Highpeak Energy Posts Downbeat Q4 Results, Joins Netskope, Descartes Systems And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

  • NewsAvi Kapoor

    Highpeak Energy Posts Downbeat Q4 Results, Joins Netskope, Descartes Systems And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

  • NewsAvi Kapoor

    Crude Oil Gains Over 5%; US Inflation Holds Steady At 2.4%

  • Press releaseGlobe Newswire

    AI Platforms, Data Infrastructure, and Healthcare Innovation Shape the Market Narrative

  • NewsAvi Kapoor

    US Stocks Mixed; Dow Falls 300 Points

  • NewsVandana Singh

    Kala Bio Chases 'Palantir For Biotech' Dream With New AI Platform

  • News

    12 Health Care Stocks Moving In Wednesday's Pre-Market Session

  • News

    12 Health Care Stocks Moving In Thursday's Intraday Session

  • NewsAvi Kapoor

    Why Cyclerion Therapeutics Shares Are Trading Higher By 44%; Here Are 20 Stocks Moving Premarket

  • NewsAvi Kapoor

    US Stocks Edge Higher; Dollar General Shares Jump After Upbeat Earnings

  • NewsAvi Kapoor

    Crude Oil Gains Over 1%; ISM Manufacturing PMI Falls In November

  • NewsAvi Kapoor

    Dow Dips 200 Points; Q32 Bio Shares Jump

  • NewsAvi Kapoor

    Why Autodesk Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket

  • NewsAvi Kapoor

    Crude Oil Falls Sharply; Carnival Posts Upbeat Earnings

  • NewsAvi Kapoor

    Nasdaq Jumps 150 Points; US Pending Home Sales Rise

  • News

    KALA BIO Shares Halted On Code News Pending

  • News

    12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.